Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (688621.SS) SHH
51.97
-0.53(-1.01%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Beijing Sun-Novo Pharmaceutical Research Co., Ltd.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1556
First IPO Date
June 21, 2021
Key Executives
| Name | Title | Pay | Year Born |
| Dao Sheng Xie | Core Technical Staff | 0 | 1985 |
| Ming Juan Wang | Core Technical Staff | 0 | 1976 |
| Guangtao Hao | Deputy GM & Core Technician | 0 | 1980 |
| Huan Luo | Deputy GM & Director | 0 | 1984 |
| Yan Shao | Deputy General Manager | 0 | 1978 |
| Li Ping Wei | Secretary & Director | 0 | 1989 |
| Yujing Liu | GM & Director | 0 | 1982 |
| Zhi Jiao Zhang | Accounting Supervisor & Director | 0 | 1979 |
| Yuanbo Li | Deputy General Manager | 0 | 1979 |
Description
Beijing Sun-Novo Pharmaceutical Research Co., Ltd., a contract research company, engages in the research and development of chemical drugs and peptide drugs in China. The company offers small molecule chemical generic drugs; peptide products; and drugs for indications, such as impetigo, acne, renal anemia, chronic kidney disease dialysis patient hyper parathyroid hormone, analgesia, and other symptoms. It also provides packaging material compatibility test, impurity research, extract research, migration research, safety evaluation, and other research services; consistency evaluation services; clinical research services; registration consulting and agency services; and range of pharmacokinetics-pharmacodynamics and GLP bioanalysis services, including pharmacokinetic bioanalysis, immunogenic biology analysis, pharmacodynamics, and biomarker bioanalysis services. The company was founded in 2009 and is based in Beijing, China.